17 Jul

HEALTHBEACON TO SPONSOR AT THE MAGIC FOUNDATION’S 26TH ANNUAL CONVENTION.

[Boston, MA., Jul. 17 2020] – HealthBeacon, a medication adherence technology company that develops smart tools for managing medication, is proud to sponsor the MAGIC Foundation’s 26th Annual Virtual Convention on July 17th – July 18th, 2020.

The MAGIC Foundation is the global leader in endocrine health, advocacy, education and support for human growth disorders. HealthBeacon is proud to sponsor the MAGIC Foundation Convention for the 3rd consecutive year. Laura Hamilton, CEO of North America will be showcasing HealthBeacon’s Injection Care Management System.  She notes, “The MAGIC Foundation Convention provides a powerful opportunity to connect with patients on injectable Growth Hormone Therapy, as well as Pediatric Endocrinologists. This year we are pleased to share research regarding medication adherence from a Growth Hormone patient study and to capture new insights from patients through our virtual booth. We are excited to offer enrollment to a complimentary HealthBeacon program, exclusively available to attendees of this year’s MAGIC Foundation Convention.”

In years past, HealthBeacon has had the opportunity to meet endearing patients, along with their families and hear their experiences in managing their daily medication routine.Although this year’s event is virtual, we look forward to hearing patient stories, connecting with Clinicians and continuing to support the great work of the MAGIC Foundation.

About HealthBeacon

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication. HealthBeacon’s FDA-cleared “smart sharps bin” tracks patient injection history, provides personalized interactive reminders and safely stores used injections. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  HealthBeacon’s integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across 14 countries with >400,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%.

For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

About MAGIC Foundation
The MAGIC Foundation was incorporated in the state of Illinois and received 501(C)3 non-profit status October 29, 1989. Since its inception, the Foundation has grown to include support services for adults who were also impacted by these disorders.

05 May

HealthBeacon Launches COVID-19 Services for ‘At Risk’ Patients

HEALTHBEACON LAUNCHES COVID-19 SERVICES FOR ‘AT RISK’ PATIENTS

Irish Digital Health Company Adapts Services Helping Patients on Injection Therapy Access Critical Medications

Now Available to Laya Healthcare Members

[Dublin, Ireland., May 5, 2020] – HealthBeacon a medication adherence technology company, has launched a new Covid-19 support offering for patients on injectable therapies which is now available to laya healthcare’s 600,000 members.

HealthBeacon has developed the world’s first Injection Care Management System for patients that self-administer injectable medication in their homes. HealthBeacon eases the burden of managing patients’ injectable medications from home through their Smart Sharps Bin Technology.

During this time of crisis, it is critical that people with chronic conditions continue to take their medications as prescribed by their healthcare professionals while maintaining social distancing and avoiding unnecessary exposures. For this reason, the HealthBeacon Injection Care Management System is being expanded to offer additional services to further support individuals in their homes.

The enhanced HealthBeacon offering, now available to laya healthcare members includesvirtual care support, coordination of medication delivery, medical waste collection, and home monitoring with the HealthBeacon Smart Sharps Bin. This service will reduce the number of visits to the pharmacy and hospitals for those ‘at-risk’ while ensuring patients will continue to take critical medications.

Jim Joyce, CEO HealthBeacon said; “We are delighted that laya healthcare has agreed to cover this service for their members during these unprecedented times, it is critical to adapt and innovate to ensure continued support to patients.  Digital health technology has a huge role to play during COVID-19 and we want to ensure vulnerable patients are able to access critical medications.”

John McCall, Director of Claims and Provider Relations at laya healthcare welcomed the innovative support provided by HealthBeacon to its members “Members who need to regularly inject themselves at home will welcome this new service we’re now offering as part of our enhanced healthcare benefits available at no additional cost until the end of June 2020. It’s just another way we’re looking after our members, always.

ABOUT HEALTHBEACON

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%. For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

Media Contact:

Mary Principe | comms@healthbeacon.com

10 Jan

HealthBeacon to present on their US expansion during the 37th Annual J.P. Morgan Healthcare Conference

HEALTHBEACON TO PRESENT ON THEIR U.S. EXPANSION FOR THEIR FDA CLEARED ADHERENCE TECH FOR INJECTABLE MEDICATION DURING THE  37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

[Boston, MA., Jan. 10 2020] – HealthBeacon, a medication adherence technology company that develops smart tools for managing medication, today announced that Jim Joyce, CEO and Co-Founder, will present at the Digital Medicine & Medtech Showcase™ in San Francisco on Tuesday, January 14th at 11:00 am Pacific time.

Jim Joyce, CEO will be announcing HealthBeacon’s US expansion for their FDA cleared adherence technology for injectable medication at Digital Medicine & Medtech Showcase as follows:

Date: Tuesday, January 14, 2020

Time: 11AM (PST)

Room: Balboa (Level 4)

Venue: Parc 55 – A Hilton Hotel, 55 Cyril Magnin Street, San Francisco, CA (United States)

 

Jim Joyce, CEO & Co-Founder

ABOUT HEALTHBEACON

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%. For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

Media Contact:

Mary Principe | comms@healthbeacon.com

30 Dec

HealthBeacon’s FPL Network held at Microsoft EMEA HQ in Dublin

 

 

(Dublin, Ireland – September 3rd, 2019)  HealthBeacon sponsors of the Future Pharma Leader Network (FPL) and Microsoft collaborated in hosting an excellent event in Microsoft’s EMEA Headquarters in Dublin.

The network was addressed by Irish entrepreneurs Oliver Tattan and Pat O’Flynn and by venture investor Lisa Suennen. The network debated some critical constraints to innovation in Pharma, specifically the challenges of supporting real-world evidence advance care and the need to enhance data privacy and patient consent to secure superior clinical outcomes from medicines in common use.

 

 

 

 

 

 

 

 

 

 

 

 

 

05 Dec

BIBA Delegates Visit HealthBeacon in Dublin

HealthBeacon, a Dublin and Boston based medication adherence technology company that develops Smart Tools for Managing Medication welcomed the Boston Irish Business Association (BIBA) and its 2019 trade mission delegation to it’s Dublin headquarters on Monday, December 2nd.

BIBA Delegates at HealthBeacon HQ

HealthBeacon Co-Founders: Kieran Daly & Jim Joyce

 

 

 

 

 

 

 

 

The purpose of the trade mission is to look at the potential for transatlantic collaboration in order to strengthen links between businesses in Ireland and Boston. The trade mission was led by Laura Hamilton, who is the newly appointed CEO of HealthBeacon’s North American operations.

As President of the Boston Irish Business Association, it was my distinct pleasure to lead an impressive delegation on a Trade Mission across the island of Ireland visiting Belfast, Derry, Donegal, Dublin, Kildare and Cork. A highlight was visiting HealthBeacon HQ in Dublin. It’s been an incredible few weeks since joining the team as their new CEO of North America.” says Hamilton.

HealthBeacon members welcomed the Boston Irish Business Association (BIBA) and its 2019 trade mission delegation BIBA to their facility. HealthBeacon’s CEO, Jim Joyce guided delegates around the HQ touring the Data labs which has a dedicated Data Analyst team serving up valuable actionable insights and analysis, the production lab where the HealthBeacon units are assembled and configured and it’s enthusiastic customer service team which supports the HB offering to patients.

Having the BIBA delegation visit HealthBeacon in Dublin truly showcases the value of growing international business relationships, sustaining the effort, and then capitalizing on opportunities as a result of the endeavor.” Says Hamilton.

HealthBeacon’s technology has been adopted across 13 countries with over 300,000 injections tracked since its launch in 2014 and a patient acceptance rate of 80-90%. For patients that are treated on chronic injectable therapy for conditions that range from Multiple Sclerosis, Crohns Disease, Rheumatoid Arthritis, Asthma, to Severe Migraines many of them fail on therapy due to non-adherence. The data is clear that without support between 40-50% of patients will fail on therapy in the first year.

HealthBeacon’s Smart Sharps Technology has demonstrated a 25-30% increase within twelve months of initiating therapy.  The key to their success is the powerful simplicity of their technology and how it easily integrates into the patient’s routine and the prescribing clinician’s workflow.

HealthBeacon and BIBA Delegates

CEO Jim Joyce welcoming BIBA

CTO, Kieran Daly with Delegates

 

 

 

 

Sr Manager – Contracts & Reimbursements, Alan Dalton

HealthBeacon Smart Sharps Bin

3D Printer

 

04 Dec

HealthBeacon welcomes Boston Irish Business Association to its Dublin HQ

Silicon Republic: Kelly Earley is a journalist with Siliconrepublic.com

HealthBeacon’s new CEO for North America, Laura Hamilton, hopes to strengthen links between businesses in Ireland and Boston.

This week, medtech firm HealthBeacon, which is headquartered between Dublin and Boston, welcomed the Boston Irish Business Association (BIBA) and its 2019 trade mission delegation to the company’s Irish headquarters.

The trade mission was led by Cork-born Laura Hamilton, who is the newly appointed CEO for HealthBeacon’s North American operations. As well as leading the company’s US arm, Hamilton is also the current BIBA president.

The Boston delegation’s visit to HealthBeacon was one stop on a journey through Belfast, Donegal, Derry, Dublin and Cork. The purpose of the trade mission is to look at the potential for transatlantic collaboration. It is hoped that the mission will bring together high-profile US business leaders to grow and strengthen business relationships throughout Ireland.

The BIBA delegates were given a site tour and product overview of HealthBeacon’s Dublin facility, which was led by the company’s co-founder Jim Joyce, who is also a Boston native.

HealthBeacon is developing smart tools for managing medication. Its Smart Sharp Bin aims to make it easier for patients using injectable medicines to stay on track with their treatment schedule and allow carers to track a patient’s progress.

Poised for US growth

Hamilton, who was born in Cork but grew up in Boston, played an instrumental role in bringing BIBA to Ireland for the first time in 10 years.

“After years of planning and discussion, I am thrilled to lead the BIBA trade mission to Ireland, especially as the incoming HealthBeacon CEO for the North American division,” Hamilton said.

“I have been closely connected to HealthBeacon for many years and admire the leadership, the team they’ve developed and early success achieved across Europe.

“The business is poised for tremendous growth in North America through creating value in the healthcare ecosystem with a unique world leading technology, tracking patient adherence with injectable medications for chronic disease.”

To date, HealthBeacon’s platform has been used to track more than 300,000 injections in patient’s homes. The Smart Sharp Bin has been launched in 13 countries.

Joyce said: “I first got to know Laura over four years ago in her time as director of business development at the Massachusetts Biotechnology Council (MassBio) and as BIBA president. HealthBeacon are delighted to appoint a talented business innovator and welcome this important trade mission to our Irish headquarters.”

Since it was founded in 2013, HealthBeacon has raised $15m in funding. Earlier this year, the company announced plans to expand into Asia and the US.

HealthBeacon welcomes Boston Irish Business Association to its Dublin HQ